Using a CGM With Type 2 Diabetes

A continuous glucose monitor (CGM) tracks glucose throughout the day and night from a small sensor worn on the body. Instead of a single number from a fingerstick, it shows the direction glucose is heading, how meals and activity affect it, and how much of the day is spent in range. In type 2 diabetes, that continuous picture is increasingly used to guide everyday choices and conversations with a clinician.

What a CGM actually measures

A CGM measures glucose in the interstitial fluid — the fluid that surrounds cells just beneath the skin — rather than directly in the blood. A thin sensor filament sits under the skin and takes a reading every few minutes, sending values to a reader or smartphone. Because interstitial glucose lags slightly behind blood glucose, the strength of a CGM is not any single point but the trend: the shape of the curve over hours and days. This is a different kind of information from a fingerstick, which captures one moment. For background on how the technology works, see our overview of continuous glucose monitoring. This page is part of the type 2 diabetes hub.

Trends, spikes, and time in range

Because it samples continuously, a CGM surfaces patterns that spot checks miss:

• Post-meal spikes: how far and how fast glucose rises after a particular meal, and how long it takes to come back down.
• Overnight patterns: what glucose does during sleep, when no one is testing.
• Trend arrows: whether glucose is steady, rising, or falling right now — context a single value cannot give.
• Time in range: the share of the day glucose stays within an individual target band, a summary metric explained in our guide to time in range.

Seeing these patterns can make the effect of a specific food, a walk after dinner, or a change in sleep concrete rather than abstract.

Why CGMs are used in type 2 diabetes

CGMs were first widely adopted in type 1 diabetes and insulin-treated type 2 diabetes. More recently they are used more broadly in type 2 diabetes — including for some people who are not on insulin — to reveal how food, physical activity, sleep, and medication timing affect glucose. That feedback loop can support behavior change and give a clinician real-world data to work from. Whether a CGM is appropriate, and for how long, is an individual decision that depends on your situation and is best made with your care team. Our primary-care focused piece on CGM in type 2 diabetes in primary care discusses how this fits into routine visits, and managing type 2 diabetes between visits covers the day-to-day side.

Professional versus personal CGM

There are two broad ways a CGM is used:

• Personal CGM: worn on an ongoing basis and owned by the individual, who can usually see readings in real time on a phone or reader.
• Professional CGM: supplied by a clinic for a defined period. The sensor may be "blinded" or visible, and the data is typically reviewed together with a clinician afterward to characterize glucose patterns.

Both approaches aim at the same thing — turning scattered numbers into a pattern that a person and their clinician can act on.

Where decision-support fits

A CGM produces a large amount of data, and interpreting it well is where clinical decision-support has a role. Endobits is decision-support software that helps organize and interpret glucose data — such as trends and time in range — under clinician oversight. It supports the interpretation that informs a care plan; it does not diagnose or treat, and it does not replace a clinician's judgment. The aim is to make the story in the data easier to see so that the person and their care team can have a better-informed conversation.

Sources

American Diabetes Association — Continuous Glucose Monitors (CGM). Centers for Disease Control and Prevention — Monitoring Your Blood Sugar. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — Continuous Glucose Monitoring.

Related: The type 2 diabetes guide · Continuous glucose monitoring · Time in range · Managing type 2 between visits · Glossary